Close Menu

In a paper published online in advance in Science this week, investigators at Finland's University of Helsinki and elsewhere report their identification of tumor-specific mutations in the mediator complex subunit 12 (MED12) gene in 10 of 18 uterine leiomyomas they studied using an exome sequencing approach. The team also reports its analysis of 207 additional tumors, of which 70 percent showed alterations in MED12.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.